(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
ISS astronauts spy airglow and dwarf galaxy | Space photo of the day for Jan. 13, 2026 - 2Share your pick for the miniature headphones that you generally suggest!
- 37 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Far reaching Guide
- 4African nations push to recognize crimes of colonialism in Algeria
- 5Cyber Monday 2025: Save over 70% on HBO Max with this Prime Video streaming deal
- Vote in favor of your Number one Kind of Gems
- FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
- RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- Some super-smart dogs can pick up new words just by eavesdropping
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- The Century Coupe Could Be Toyota’s Most Ambitious Car Since the LFA
- The cheap health insurance promoted by Trump officials has this catch
